Chylomicronemia risk factors ranked by importance for the individual and community in 108 711 women and men

A Test in Context: Lipid Profile, Fasting Versus Nonfasting

(2017) Børge G. Nordestgaard   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease

(2016) Børge G. Nordestgaard   CIRCULATION RESEARCH

Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints--A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

(2016) B. G. Nordestgaard et al.   CLINICAL CHEMISTRY

Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine

(2016) Børge G. Nordestgaard et al.   EUROPEAN HEART JOURNAL

Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis

(2016) Simon B. Pedersen et al.   JAMA Internal Medicine

Chylomicronaemia—current diagnosis and future therapies

(2015) Amanda J. Brahm et al.   Nature Reviews Endocrinology

Lipoprotein(a): Fasting and nonfasting levels, inflammation, and cardiovascular risk

(2014) Anne Langsted et al.   ATHEROSCLEROSIS

Low Nonfasting Triglycerides and Reduced All-Cause Mortality: A Mendelian Randomization Study

(2014) M. Thomsen et al.   CLINICAL CHEMISTRY

Mendelian randomization studies in coronary artery disease

(2014) H. Jansen et al.   EUROPEAN HEART JOURNAL

Current knowledge of hypertriglyceridemic pancreatitis

(2014) Pedro Valdivielso et al.   European Journal of Internal Medicine

Triglycerides and cardiovascular disease

(2014) Børge G Nordestgaard et al.   LANCET

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

(2013) Robert A Hegele et al.   Lancet Diabetes & Endocrinology

Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication

(2012) Marianne Benn et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline

(2012) Lars Berglund et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

(2012) Anette Varbo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Severe Hypertriglyceridemia Influenced by Alcohol (SHIBA)

(2011) K. Bessembinders et al.   ALCOHOL AND ALCOHOLISM

Prevalence of Severe (500 to 2,000 mg/dl) Hypertriglyceridemia in United States Adults

(2011) Jennifer B. Christian et al.   AMERICAN JOURNAL OF CARDIOLOGY

Hypertriglyceridemia secondary to obesity and diabetes

(2011) Savitha Subramanian et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

Metabolic Implications of Menopause

(2010) Hanah Polotsky et al.   SEMINARS IN REPRODUCTIVE MEDICINE

Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults

(2009) Earl S. Ford et al.   ARCHIVES OF INTERNAL MEDICINE

Association of moderate and severe hypertriglyceridemia with obesity, diabetes mellitus and vascular disease in the Spanish working population: Results of the ICARIA study

(2009) Pedro Valdivielso et al.   ATHEROSCLEROSIS

Chylomicronemia and the Chylomicronemia Syndrome: A Practical Approach to Management

(2008) David Alexander Leaf   AMERICAN JOURNAL OF MEDICINE